Azor, Israel

Neta Zilony-Hanin

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aummune Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neta Zilony-Hanin. Retrieved from https://idiyas.com/inventor/neta-zilony-hanin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neta Zilony-Hanin: Innovator in T-Lymphocyte Binding Aptamers

Introduction

Neta Zilony-Hanin is a prominent inventor based in Azor, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target T-lymphocytes. Her innovative work has the potential to impact various therapeutic applications.

Latest Patents

Neta holds a patent for T-lymphocyte binding aptamers. This patent provides methods and compositions that target T-lymphocytes, which are crucial components of the immune system. The patent is a testament to her expertise and dedication to advancing medical science.

Career Highlights

Neta Zilony-Hanin is associated with Aummune Ltd., a company focused on developing novel immunotherapies. Her role at Aummune has allowed her to collaborate with other talented professionals in the field, enhancing the company's innovative capabilities.

Collaborations

Neta has worked alongside notable colleagues such as Irit Carmi-Levy and Zohar Pode. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in biotechnology.

Conclusion

Neta Zilony-Hanin's contributions to the field of biotechnology, particularly through her patent on T-lymphocyte binding aptamers, highlight her role as an influential inventor. Her work continues to pave the way for advancements in immunotherapy and related fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…